Nav: Home

First review of SARS-CoV-2 and COVID-19 infection models

August 24, 2020

An international collaboration between leading respiratory scientists, immunologists and clinicians, led by Centenary UTS Centre for Inflammation, has completed the first comprehensive review of all relevant animal and cellular models of SARS-CoV-2 infection and COVID-19.

The review, published in Mucosal Immunology, aims to provide a head-to-head comparison of existing disease models, including in the background of predisposing chronic diseases, and discusses the pre-clinical pipeline for the testing of new and targeted preventions and treatments for COVID-19 patients.

The researchers say that clinical trials have been hampered by the lack of this type of information derived from fundamental research.

Lead author, Dr Matt Johansen from Centenary UTS Centre for Inflammation said that everyone understands COVID-19 is causing a major "once-in-a-century global pandemic" and that there is a race to develop vaccines and identify the most effective treatments.

"Using representative animal models of SARS-CoV-2 infection, including in the background of chronic diseases such as obesity and diabetes, with validation of findings in primary human cells and tissues is the most efficient strategy," Dr Johansen said

"By discussing all the available models and their pro's and con's, this will enable other readers to make informed decisions about the advantages of each model and the suitability to their applications," he said.

Among the key points of the review are that the clearest predictor of mortality is age, with the case fatality rate rising dramatically over 60 years of age. Other predisposing factors for heightened mortality are being male, social deprivation, and chronic disease particularly chronic obstructive pulmonary disease (COPD), cardiovascular disease (CVD), obesity and diabetes.

Director of the Centenary UTS Centre for Inflammation and senior author, Professor Phil Hansbro said "Understanding the complex interactions between people with underlying diseases is critical to finding the most effective treatments for those susceptible individuals."

"A key issue is why some individuals progress to more severe lower respiratory disease but others do not, and currently scientists aren't really sure why".

"Within the Centre for Inflammation, one of the things we are trying to do is use cellular and animal models to comprehensively decipher why some people get more severe disease than others" Prof Hansbro said.
Other institutions involved in the study are Zhejiang University-University of Edinburgh Institute (Hangzhou, China), Institut Pasteur (Paris, France), Hudson Institute of Medical Research (Victoria, Australia), Monash University (Victoria, Australia), Monash Children's Hospital (Victoria, Australia), Hunter Medical Research Institute and University of Newcastle (NSW, Australia), University of Queensland (QLD, Australia), The University of Sydney and Royal Prince Alfred Hospital (NSW, Australia), Centenary Institute (NSW, Australia), ANZAC Research Institute (NSW, Australia)

University of Technology Sydney

Related Obesity Articles:

11 years of data add to the evidence for using testosterone therapy to treat obesity, including as an alternative to obesity surgery
New research covering 11 years of data presented at this year's European and International Congress on Obesity (ECOICO 2020) show that, in obese men suffering from hypogonadism (low testosterone), treatment with testosterone injections lowers their weight and improves a wide range of other metabolic parameters.
Overlap between immunology of COVID-19 and obesity could explain the increased risk of death in people living with obesity, and also older patients
Data presented in a special COVID-19 session at the European and International Congress on Obesity (ECOICO 2020) suggests that there are overlaps between the immunological disturbances found in both COVID-19 disease and patients with obesity, which could explain the increased disease severity and mortality risk faced by obese patients, and also elderly patients, who are infected by the SARS-CoV-2 virus that causes COVID-19 disease.
New obesity guideline: Address root causes as foundation of obesity management
besity management should focus on outcomes that patients consider to be important, not weight loss alone, and include a holistic approach that addresses the root causes of obesity, according to a new clinical practice guideline published in CMAJ (Canadian Medical Association Journal)
Changing the debate around obesity
The UK's National Health Service (NHS) needs to do more to address the ingrained stigma and discrimination faced by people with obesity, says a leading health psychologist.
Study links longer exposure to obesity and earlier development of obesity to increased risk of type 2 diabetes
Cumulative exposure to obesity could be at least as important as actually being obese in terms of risk of developing type 2 diabetes (T2D), concludes new research published in Diabetologia (the journal of the European Association for the Study of Diabetes [EASD]).
How much do obesity and addictions overlap?
A large analysis of personality studies has found that people with obesity behave somewhat like people with addictions to alcohol or drugs.
Should obesity be recognized as a disease?
With obesity now affecting almost a third (29%) of the population in England, and expected to rise to 35% by 2030, should we now recognize it as a disease?
Is obesity associated with risk of pediatric MS?
A single-center study of 453 children in Germany with multiple sclerosis (MS) investigated the association of obesity with pediatric MS risk and with the response of first-line therapy in children with MS.
Women with obesity prior to conception are more likely to have children with obesity
A systematic review and meta-analysis identified significantly increased odds of child obesity when mothers have obesity before conception, according to a study published June 11, 2019 in the open-access journal PLOS Medicine by Nicola Heslehurst of Newcastle University in the UK, and colleagues.
Obesity medicine association announces major updates to its adult obesity algorithm
The Obesity Medicine Association (OMA) announced the immediate availability of the 2019 OMA Adult Obesity Algorithm, with new information for clinicians including the relationship between Obesity and Cardiovascular Disease, Diabetes Mellitus, Dyslipidemia, and Cancer; information on investigational Anti-Obesity Pharmacotherapy; treatments for Lipodystrophy; and Pharmacokinetics and Obesity.
More Obesity News and Obesity Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: IRL Online
Original broadcast date: March 20, 2020. Our online lives are now entirely interwoven with our real lives. But the laws that govern real life don't apply online. This hour, TED speakers explore rules to navigate this vast virtual space.
Now Playing: Science for the People

#574 State of the Heart
This week we focus on heart disease, heart failure, what blood pressure is and why it's bad when it's high. Host Rachelle Saunders talks with physician, clinical researcher, and writer Haider Warraich about his book "State of the Heart: Exploring the History, Science, and Future of Cardiac Disease" and the ails of our hearts.
Now Playing: Radiolab

There are so many ways to fall–in love, asleep, even flat on your face. This hour, Radiolab dives into stories of great falls.  We jump into a black hole, take a trip over Niagara Falls, upend some myths about falling cats, and plunge into our favorite songs about falling. Support Radiolab by becoming a member today at